
Unnecessary Use of Placebo Controls
The Case of Asthma Clinical Trials
Arch Intern Med. 2002;162:1673-1677.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
THE ETHICS of placebo-controlled clinical trials has generated considerable
controversy in recent years. Critics, often citing the Declaration of Helsinki,
have argued that use of placebo controls is unethical in trials of medications
to treat conditions for which proven effective treatments exist. Defenders
of placebo-controlled trials contend that the alternative of clinical trials
that compare active treatments without placebo controls are often subject
to serious methodological weaknesses. In the present article we develop a
middle-ground position on the ethics of placebo-controlled trials, which is
applied to recent clinical trials of treatments for asthma. Questions are
raised about 3 recent placebo-controlled asthma trials on the grounds that
the scientific questions that these trials were designed to answer did not
require use of placebo. However, use of placebo controls in initial trials
of investigational treatments is defended, provided that patient volunteers
randomized to placebo are not exposed to serious risks of irreversible . . . [Full Text of this Article]BACKGROUND
THE ETHICAL DEBATE
TYPOLOGY OF PLACEBO-CONTROLLED TRIALS
PLACEBO-CONTROLLED TRIALS IN ASTHMA Trials of Combination Therapy Comparison of 2 Dosing Regimens Can Informed Consent Justify Placebo Controls? Initial Trials of Investigational Agents CONCLUSIONS
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Ethical Assessment of Clinical Asthma Trials Including Children Subjects
Coffey et al.
Pediatrics 2004;113:87-94.
ABSTRACT
| FULL TEXT
Continued Need for Placebo in Many Cases, Even When There Is Effective Therapy
Miller and Shorr
Arch Intern Med 2003;163:373-373.
FULL TEXT
Continued Need for Placebo in Many Cases, Even When There Is Effective Therapy
Temple and Meyer
Arch Intern Med 2003;163:371-371.
FULL TEXT
|